Adipokines and aging

Journal of Atherosclerosis and Thrombosis

Volumn 18, Issue 7, 2011, Pages 545-550

  Arai, Yasumichi ^a   Takayama, Michiyo ^a   Abe, Yukiko ^a   Hirose, Nobuyoshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adipokine; Centenarians; Insulin sensitivity; Longevity

Indexed keywords

ADIPOCYTOKINE; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADIPOSE TISSUE; AGING; ATHEROSCLEROSIS; ENERGY METABOLISM; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOATROPHY; LIPODYSTROPHY; NONHUMAN; OBESITY; PHENOTYPE; REVIEW;

ADIPOKINES; ADIPONECTIN; ADIPOSE TISSUE; AGED, 80 AND OVER; AGING; ANIMALS; HUMANS; INSULIN; INSULIN RESISTANCE; MICE; MUTATION; OBESITY; PHENOTYPE; PROGNOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79960869697     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.7039     Document Type: Review

References (47)

1. Kershaw EE, Flier JS: Adipose tissue as an endocrine organ. J Clin Endocrinol Metab, 2004; 89: 2548-2556
2. Ridker PM, Buring JE, Cook NR, Rifai N: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation, 2003; 107: 391-397
3. Tilg H, Moschen AR: Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol, 2006; 6: 772-783
4. Unger RH: Longevity, lipotoxicity and leptin: the adipocyte defense against feasting and famine. Biochimie, 2005; 87: 57-64
5. Bluher M, Kahn BB, Kahn CR: Extended longevity in mice lacking the insulin receptor in adipose tissue. Science, 2003; 299: 572-574
6. Franceschi C, Monti D, Sansoni P, Cssarizza A: The immunology of exceptional individuals: the lesson of centenarians. Immunol Today, 1995; 16: 12-16
7. Hitt R, Young-Xu Y, Sliver M, Perls T: Centenarians: the older you get, the healthier you have been. Lancet, 1999; 345: 652
8. Arai Y, Kojima T, Takayama M, Hirose N:The metabolic syndrome, IGF-1, and onsulin action. Mol Cell Endocrinol, 2009; 299: 124-128
9. Matsuzawa Y: Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med, 2006; 3: 35-42
10. Rasouli N, Kern PA: Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab, 2008; 93(11 Suppl 1): S64-S73
11. Gabriely I, Ma XH, Yang XM, Atzmon G, Rajala MW, Berg AH, Scherer P, Rossetti L, Barzilai N: Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: An adipokine-mediated process? Diabetes, 2002; 51: 2951-2958
12. Barzilai N, Banerjee S, Hawkins M, Chen W, Rossetti L: Caloric restriction reverses hepatic insulin resistance in aging rats by decreasing visceral fat. J Clin Invest, 1998; 101: 1353-1361
13. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A: Dwarf mice and the ageing process. Nature, 1996; 384(6604): 33
14. Wang Z, Al-Regaiey KA, Masternak MM, Bartke A: Adipocytokines and lipid levels in Ames dwarf and calorie-restricted mice. J Gerontol A Biol Sci Med Sci, 2006; 61: 323-331
15. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y: Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients. Arterioscler. Thromb Vasc Biol, 2000; 20: 1595-1599
16. Trujillo ME, Scherer PE: Adipose Tissue-Derived Factors: Impact on Health and Disease. Endocr Rev, 2006; 27: 762-778
17. Otabe S, Yuan X, Fukutani T, Wada N, Hashinaga T, Nakayama H, Hirota N, Kojima M, Yamada K: Overexpression of human adiponectin in transgenic mice results in suppression of fat accumulation and prevention of premature death by high-calorie diet. Am J Physiol Endocrinol Metab, 2007; 293: E210-E218
18. Garg A, Agarwal AK: Lipodystrophies: disorders of adipose tissue biology. Biochim Biophys Acta, 2009; 1791: 507-513
19. Garg A: Acquired and Inherited Lipodystrophies. N Engl J Med, 2004; 350: 1220-1234
20. Fiorenza CG, Chou SH, Mantzoros CS: Lipodystrophy: pathophysiology and advances in treatment. Nat Rev Endocrinol, 2010 Nov 16. [Epub ahead of print]
21. Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, DePaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A: Leptin-replacement therapy for lipodystrophy. N Engl J Med, 2002; 346: 570-578
22. Hegele RA, Joy TR, Al-Attar SA, Rutt BK: Thematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism. J Lipid Res, 2007; 48: 1433-1444
23. Capeau J, Magré J, Caron-Debarle M, Lagathu C, Antoine B, Béréziat V, Lascols O, Bastard JP, Vigouroux C: Human lipodystrophies: genetic and acquired diseases of adipose tissue. Endocr Dev, 2010; 19: 1-20
24. Caron M, Auclair M, Donadille B, Béréziat V, Guerci B, Laville M, Narbonne H, Bodemer C, Lascols O, Capeau J, Vigouroux C: Human lipodystrophies linked to mutations in A-type lamins and to HIV protease inhibitor therapy are both associated with prelamin A accumulation, oxidative stress and premature cellular senescence. Cell Death Differ, 2007; 14: 1759-1767
25. Araújo-Vilar D, Lattanzi G, González-Méndez B, Costa-Freitas AT, Prieto D, Columbaro M, Mattioli E, Victoria B, Martínez-Sánchez N, Ramazanova A, Fraga M, Beiras A, Forteza J, Domínguez-Gerpe L, Calvo C, Lado-Abeal J: Site-dependent differences in both prelamin A and adipogenic genes in subcutaneous adipose tissue of patients with type 2 familial partial lipodystrophy. J Med Genet, 2009; 46: 40-48
26. Korf B: Hutchinson-Gilford progeria syndrome, aging, and the nuclear lamina. N Engl J Med, 2008; 358: 552-555
27. Hennekam RC: Hutchinson-Gilford progeria syndrome: review of the phenotype. Am J Med Genet A, 2006; 140: 2603-2624
28. Goldman RD, Shumaker DK, Erdos MR, Eriksson M, Goldman AE, Gordon LB, Gruenbaum Y, Khuon S, Mendez M, Varga R, Collins FS: Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A, 2004; 101: 8963-8968
29. McClintock D, Gordon LB, Djabali K: Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody. Proc Natl Acad Sci U S A, 2006; 103: 2154-2159
30. Ragnauth CD, Warren DT, Liu Y, McNair R, Tajsic T, Figg N, Shroff R, Skepper J, Shanahan CM: Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation, 2010; 121: 2200-2210
31. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA, 2002; 287: 356-359
32. Kobayashi J, Nishimura K, Matoba M, Maekawa N, Mabuchi H: Generation and gender differences in the components contributing to the diagnosis of the metabolic syndrome according to the Japanese criteria. Circ J, 2007; 71: 1734-1737
33. Paolisso G, Gambardella A, Ammendola S, D'Amore A, Balbi V, Varricchio M, D'Onofrio F: Glucose tolerance and insulin action in healthy centenarians. Am J Physiol Endocrinol Metab, 2006; 270: E890-E894
34. Louhija J: Finnish centenarians: a clinical epidemiological study (Thesis/Dissertation). 1994. Helsinki University Press, Finland
35. Motta M, Bennati E, Ferlito L, Malaguarnera M, Motta L: Successful aging in centenarians: myths and reality. Arch Gerontol Geriatr, 2005; 40: 241-251
36. Takayama M, Hirose N, Arai Y, Gondo Y, Shimizu K, Ebihara Y, Yamamura K, Nakazawa S, Inagaki H, Masui Y, Kitagawa K: Morbidity of Tokyo-Area Centenarians and Its Relationship to Functional Status. J. Gerontol. A Biol Sci Med Sci, 2007; 62: 774-782
37. Barzilai N, Atzmon G, Schechter C, Schaefer EJ, Cupples AL, Lipton R, Cheng S, Shuldiner AR: Unique Lipoprotein Phenotype and Genotype Associated With Exceptional Longevity. JAMA, 2003; 290: 2030-2040
38. Arai Y, Hirose N: Aging and HDL metabolism in elderly people more than 100 years old. J Atheroscler Thromb, 2004; 11: 246-252
39. Paolisso G, Gambardella A, Balbi V, Ammendola S, D'Amore A, Varricchio M: Body composition, body fat distribution, and resting metabolic rate in healthy centenarians. Am J Clin Nutr, 1995; 62: 746-750
40. Arai Y, Nakazawa S, Kojima T, Takayama M, Ebihara Y, Shimizu K, Yamamura K, Homma S, Osono Y, Gondo Y, Masui Y, Inagaki H, Kitagawa K, Hirose N: High adiponectin concentration and its role for longevity in female centenarians. Geriatr Gerontol Int, 2006; 6: 32-39
41. Bik W, Baranowska-Bik A, Wolinska-Witort E, Martynska L, Chmielowska M, Szybinska A, Broczek K, Baranowska B: The relationship between adiponectin levels and metabolic status in centenarian, early elderly, young and obese women. Neuro Endocrinol Lett, 2006; 27: 493-500
42. Atzmon G, Pollin T, Crandall J, Tanner K, Schechter CB, Scherer PE, Rincon M, Siegel G, Katz M, Lipton RB, Shuldiner AR, Barzilai N: Adiponectin levels and genotype: a poptential regulator of life span in humans. J. Gerontol. A Biol Sci Med Sci, 2008; 63A: 447-453
43. Minamino T, Orimo M, Shimizu I, Kunieda T, Yokoyama M, Ito T, Nojima A, Nabetani A, Oike Y, Matsubara H, Ishikawa F, Komuro I: A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med, 2009; 15: 1082-1087
44. Arai Y, Takayama M, Gondo Y, Inagaki H, Yamamura K, Nakazawa S, Kojima T, Ebihara Y, Shimizu K, Masui Y, Kitagawa K, Takebayashi T, Hirose N: Adipose endocrine function, insulin-like growth factor-1 axis, and exceptional survival beyond 100 years of age. J Gerontol A Biol Sci Med Sci, 2008; 63: 1209-1218
45. Bouillanne O, Dupont-Belmont C, Hay P, Hamon-Vilcot B, Cynober L, Aussel C: Fat mass protects hospitalized elderly persons against morbidity and mortality. Am J Clin Nutr, 2009; 90: 505-510
46. Noori N, Kovesdy CP, Dukkipati R, Kim Y, Duong U, Bross R, Oreopoulos A, Luna A, Benner D, Koppke JD, Kalantar-Zadeh K: Survival predictability of lean and fat mass in men and women undergoing maintenance hemodialysis. Am J Clin Nutr. 2010; 92: 1060-1070
47. Uno K, Katagiri H, Yamada T, Ishigaki T, Ogihara T, Imai J, Hasegawa Y, Gao J, Kaneko K, Iwasaki H, Ishihara H, Sasano H, Inukai K, Mizuguchi H, Asano T, Shiota M, Nakazato M, Oka Y: Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity. Science, 2006; 312: 1656-1659